Tumor growth was significantly reduced in EnanDIM-C treated mice (Fig. 4e, f), and immunohistochemical analysis of tumors showed a significant increase of CD8+ T cells within the tumor (Fig. 4g, h). This evidence concerns the gene CD8A and neoplasm.